IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Breast Neoplasms
US Oncology Researchmonoclonal_antibodyPhase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 65/ 100
Competitive context
177 Active assets in the Breast Neoplasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Docetaxel Universitas Airlangga | Phase 4 | BB |
TAMOXIFEN Eli Lilly and Company | Phase 3 | BB |
Cyclophosphamide Merck Sharp & Dohme LLC | Phase 4 | BB |
Inno-206 Merck Sharp & Dohme LLC | Phase 4 | BB |
Letrozole Fujian Cancer Hospital | Phase 4 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →